Azurite Microorganisms

BiotechnologySeries BBeijing, Chinabluepha.com

Latest round

Series B

Last raised

Aug 2021

Total raised

$66M

Investors

5

About Azurite Microorganisms

Based in China, and founded in 2016 by its CEO Dr.Li Teng, Azurite Microorganisms trading as Bluepha operates as an enterprise engaged in molecular and material innovation based on synthetic biotechnology. Ltd. Azurite Microorganisms is dedicated to the design, development, manufacture, and sales of new bio-based molecules and materials, helping B-end customers in many industries, such as consumer goods, food, medical, agriculture, and industry.0 synthetic biology research and development platform SynBio_OS, as well as the research and development of new product pipelines such as regenerative medicine materials and engineered probiotic.

Who invested in Azurite Microorganisms

5 investors across 1 round

See all investors in Azurite Microorganisms

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 9, 2021

    Amount

    $66M

    Investors

    Locked

Questions about Azurite Microorganisms

Who invested in Azurite Microorganisms?

Azurite Microorganisms has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Azurite Microorganisms raised?

Azurite Microorganisms has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Azurite Microorganisms last raise money?

Azurite Microorganisms's most recent round on record is a Series B, in Aug 2021.

What does Azurite Microorganisms do?

Based in China, and founded in 2016 by its CEO Dr.

Where is Azurite Microorganisms headquartered?

Azurite Microorganisms is headquartered in Beijing, China.

Which VCs invest in companies like Azurite Microorganisms?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Azurite Microorganisms's stage. Their profiles are linked below.

Raising like Azurite Microorganisms? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.